Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Metabolomic study of the LDL receptor null mouse fed a high-fat diet reveals profound perturbations in choline metabolism that are shared with ApoE null mice.

Cheng KK, Benson GM, Grimsditch DC, Reid DG, Connor SC, Griffin JL.

Physiol Genomics. 2010 May;41(3):224-31. doi: 10.1152/physiolgenomics.00188.2009. Epub 2010 Mar 2.

PMID:
20197419
2.

Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, Boyle JJ, Haskard DO.

Am J Pathol. 2007 Jan;170(1):416-26.

4.

Short term arterial remodelling in the aortae of cholesterol fed New Zealand white rabbits shown in vivo by high-resolution magnetic resonance imaging - implications for human pathology.

Hegyi L, Hockings PD, Benson MG, Busza AL, Overend P, Grimsditch DC, Burton KJ, Lloyd H, Whelan GA, Skepper JN, Vidgeon-Hart MP, Carpenter AT, Reid DG, Suckling KE, Weissberg PL.

Pathol Oncol Res. 2004;10(3):159-65. Epub 2004 Sep 25.

5.

Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development.

Parkin SL, Pritchett JP, Grimsditch DC, Bruckdorfer KR, Sahota PK, Lloyd A, Overend P, Benson GM.

Biochem Soc Trans. 2004 Feb;32(Pt 1):128-30.

PMID:
14748730
6.

Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.

Murphy N, Bruckdorfer KR, Grimsditch DC, Overend P, Vidgeon-Hart M, Groot PH, Benson GM, Graham A.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1615-20. Epub 2003 Jul 3.

PMID:
12842836
7.

Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F(1)B hamster.

McAteer MA, Grimsditch DC, Vidgeon-Hart M, Benson GM, Salter AM.

Br J Nutr. 2003 Mar;89(3):341-50.

PMID:
12628029
8.

Hypercholesterolaemia and circulating levels of CXC chemokines in apoE*3 Leiden mice.

Murphy N, Grimsditch DC, Parkin S, Vidgeon-Hart MP, Overend P, Groot PH, Graham A, Benson GM.

Atherosclerosis. 2002 Jul;163(1):69-77.

PMID:
12048123
9.

C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.

Grimsditch DC, Penfold S, Latcham J, Vidgeon-Hart M, Groot PH, Benson GM.

Atherosclerosis. 2000 Aug;151(2):389-97.

PMID:
10924715
10.

Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.

Turner NC, Dolan JS, Grimsditch D, Lamb J, Worby A, Murray KJ, Coates WJ, Warrington BH.

Br J Pharmacol. 1994 Apr;111(4):1198-204.

11.

The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.

Murray KJ, Eden RJ, Dolan JS, Grimsditch DC, Stutchbury CA, Patel B, Knowles A, Worby A, Lynham JA, Coates WJ.

Br J Pharmacol. 1992 Oct;107(2):463-70.

12.

Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.

Murray KJ, Eden RJ, England PJ, Dolan J, Grimsditch DC, Stutchbury CA, Patel B, Reeves ML, Worby A, Torphy TJ, et al.

Agents Actions Suppl. 1991;34:27-46.

PMID:
1665307

Supplemental Content

Loading ...
Support Center